ReviewJournal of clinical medicine2023

Antibody-Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?

Pierluigi De Santis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.